Cellect Biotechnology (APOP) Short Interest Ratio & Short Volume

Short interest is the volume of Cellect Biotechnology shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 36,000 shares of APOP short. Learn More on Cellect Biotechnology's current short interest.

Cellect Biotechnology saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 36,000 shares, a decline of 54.1% from the previous total of 78,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Cellect Biotechnology: NEXGEL, Inc. (0.51%), Microbot Medical Inc. (1.20%), GlucoTrack, Inc. (0.47%), PetVivo Holdings, Inc. (1.49%), Biotricity, Inc. (4.54%), Meihua International Medical Technologies Co., Ltd. (1.88%), T2 Biosystems, Inc. (11.64%), PAVmed Inc. (5.35%), STRATA Skin Sciences, Inc. (1.17%), Akili, Inc. (0.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.75 billion), S&P Global Inc. ($7.73 billion), Charter Communications, Inc. ($5.40 billion), Snowflake Inc. ($4.50 billion), Canadian Pacific Kansas City Limited ($4.39 billion), Uber Technologies, Inc. ($4.21 billion), Wayfair Inc. ($4.15 billion), Palo Alto Networks, Inc. ($3.27 billion), Teladoc Health, Inc. ($2.78 billion), and DoorDash, Inc. ($2.62 billion). View all of the most shorted stocks.

Short selling APOP is an investing strategy that aims to generate trading profit from Cellect Biotechnology as its price is falling. APOP shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cellect Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APOP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APOP, twice per month. The most recent reporting period available is October, 15 2021.